Setting a New Standard for Processing Speed

Beckman Coulter is interfacing its CyAnTM flow cytometer with IntelliCyt’s HyperCyt system, a configuration that offers researchers the fastest flow cytometric cell analysis available. The CyAn provides acquisition rates of up to 80,000 events per second, which, combined with the continuous, rapid sampling capabilities offered by the HyperCyt autosampler and HyperView™ Data Analysis Software, enables 384-well plates to be processed in as little as 10 minutes. The instrument package will allow high-speed processing to be used in many cell-surface and intracellular flow cytometry applications.

“The combination of these products will provide the capability for flow cytometry to reach an entirely new market segment where high throughput is essential,” said Brad Calvin, Vice President of Beckman Coulter’s Flow Cytometry Business Centre. “When the multidimensional cellular analysis capabilities of flow cytometry combine with high-throughput processing, more information can be generated from a single analysis than can be obtained with the drug discovery tools that are currently available.”

“We are very excited about this opportunity to work with Beckman Coulter. They have an extensive global footprint for both sales and support, which allows our products to reach a large and diverse customer set,” said R. Terry Dunlay, President and CEO of IntelliCyt. “With this relationship, we believe that HyperCyt will continue to advance and expand the use of flow cytometers to address the screening needs of modern drug discovery and life science research by delivering a new benchmark in the speed of sampling and data processing.

”The companies have also reached an agreement on distribution of Intellicyt’s Hypercyt System. The partnership provides Beckman Coulter with exclusive distribution rights for the HyperCyt system outside of North America and co-exclusive distribution rights for the HyperCyt system for use on its CyAn flow cytometer in North America. IntelliCyt will continue direct sales and support of the HyperCyt system in North America.